NeuroTherm Buy Boosts St. Jude’s Pain Business
This article was originally published in Start Up
Executive Summary
NeuroTherm makes devices for radiofrequency ablation of nerves in painful facet joints in the neck or back to treat chronic pain. Although it markets neurostimulators, St. Jude currently does not sell any devices in the radio-frequency ablation segment of the pain-therapy market.
You may also be interested in...
St. Jude Medical Receives CE Mark For Prodigy Neurostimulation System
In March, St. Jude Medica received CE mark for its Prodigy Chronic Pain System with Burst Technology. According to the company, Prodigy is the only spinal cord stimulation device on the market that offers both tonic and burst stimulation to patients suffering from chronic pain.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.